Loading...
10 Brazil OB/GYN Drugs Reports
Country Covered: Brazil
Study Period: 2019 - 2029
Major Players: Pfizer Inc., Teva Pharmaceutical Industries Limited, Novartis International AG, Takeda Pharmaceutical Company Limited, Bayer AG
Country Covered: Brazil
Study Period: 2021 - 2029
Major Players: Bayer AG, Novartis AG, Pfizer, Inc, Novo Nordisk Corporation, AbbVie Inc.(Allergan Plc)
Country Covered: Brazil
Study Period: 2019 - 2029
Major Players: Amgen Inc. , Eli Lilly and Co. , F. Hoffmann-La Roche Ltd , Merck & Co., Inc. , Allergan plc
Country Covered: Brazil
Study Period: 2021 - 2029
Major Players: Teva Pharmaceuticals, Bayer AG, Pfizer Inc., Amneal Pharmaceuticals LLC, Mayne Pharma
Country Covered: Brazil
Study Period: 2019 - 2029
Major Players: Bayer AG, Pfizer Inc., AbbVie Inc. , Teva Pharmaceutical Industries, AstraZeneca
Country Covered: Brazil
Study Period: 2019 - 2029
Major Players: Melinta Therapeutics Inc., Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline, Cipla Inc.
Country Covered: Brazil
Study Period: 2019 - 2029
Major Players: Upsher-Smith Laboratories, Viatris Inc., Cadila Pharmaceuticals, Bayer AG, Stada Arzneimittel AG
Country Covered: Brazil
Study Period: 2019 - 2029
Major Players: Gynesonics, Medtronic, INSIGHTEC, Myovant Sciences GmbH, Boston Scientific Corporation
Country Covered: Brazil
Study Period: 2019 - 2029
Major Players: Novartis AG, Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sanofi
Country Covered: Brazil
Study Period: 2019 - 2029
Major Players: Ferring Holding SA, TherapeuticsMD Inc., AbbVie Inc., Pfizer Inc., GSK plc